ABUS Arbutus Biopharma Corp.
Fundamentals / CIK 0001447028 / USDArbutus Biopharma Corp. reported $181.5M in revenue and net income of $219.9M for the trailing twelve months ended September 30, 2026 (down 43.5% year over year), with a 81.1% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ABUS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$181.5M -43.5% YoY
-
Operating Income TTM$147.2M 81.1% margin
-
Net Income TTM$219.9M 121.2% net margin
-
Diluted EPS TTM$1.10 Split-adjusted
-
Free Cash Flow TTM-$39.64M -21.8% FCF margin
-
Cash & ST Investments Sep 30, 2026$337.5M Total debt: $328K
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.08M | $6.17M | $18.14M | $39.02M | $10.99M | $6.91M | $6.01M | $5.95M | $10.70M | $1.49M |
| Research & Development | $25.24M | $54.04M | $73.70M | $84.41M | $65.50M | $49.34M | $57.60M | $57.93M | $62.68M | $61.25M |
| Total Operating Expenses | $52.24M | $82.49M | $96.24M | $104.5M | $84.51M | $64.72M | $149.9M | $95.72M | $121.6M | $493.1M |
| Operating Income | -$38.16M | -$76.32M | -$78.10M | -$65.46M | -$73.52M | -$57.81M | -$143.9M | -$89.78M | -$110.9M | -$491.6M |
| EBITDA | -$37.80M | -$74.94M | -$76.70M | -$64.03M | -$71.77M | -$55.83M | -$141.9M | -$87.60M | -$108.9M | -$490.5M |
| Interest Income | $4.07M | $6.58M | $5.69M | $2.19M | $127K | $741K | $2.11M | $3.05M | $1.54M | $1.39M |
| Interest Expense | $97K | $137K | $459K | $1.73M | $2.86M | $4.01M | $2.11M | $226K | $261K | $0 |
| Income Before Tax | -- | -- | -- | -- | -- | -$63.74M | -$166.4M | -$61.34M | -$108.7M | -$489.2M |
| Income Tax Expense | $0 | $0 | $0 | $4.44M | $0 | $0 | -$12.66M | -$4.28M | -$24.32M | -$105.0M |
| Net Income | -$33.50M | -$69.92M | -$72.85M | -$69.46M | -$76.25M | -$63.74M | -$153.7M | -$57.06M | -$84.41M | -$384.2M |
| Basic EPS | -$0.17 | -$0.38 | -$0.44 | -$0.46 | -$0.83 | -$1.00 | -$2.89 | -$1.21 | -$1.56 | -$7.24 |
| Diluted EPS | -$0.17 | -$0.38 | -$0.44 | -$0.46 | -$0.83 | -$1.00 | -$2.89 | -$1.21 | -$1.56 | -$7.24 |
| Basic Shares Outstanding | 191.6M | 185.6M | 166.0M | 150.9M | 106.2M | 75.8M | 57.1M | 55.3M | 54.7M | 53.1M |
| Diluted Shares Outstanding | 191.6M | 185.6M | 166.0M | 150.9M | 106.2M | 75.8M | 57.1M | 55.3M | 54.7M | 53.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $299K | $1.01M | $179.1M | $1.05M | $529K | $10.74M | $1.76M | $1.57M |
| Research & Development | $2.62M | $2.90M | $4.12M | $5.01M | $5.78M | $5.50M | $8.96M | $8.81M |
| Total Operating Expenses | $10.79M | $6.98M | $10.22M | $6.34M | $9.19M | $9.25M | $27.46M | $15.51M |
| Operating Income | -$10.49M | -$5.96M | $168.9M | -$5.29M | -$8.66M | $1.49M | -$25.70M | -$13.93M |
| EBITDA | -$10.48M | -$5.95M | $168.9M | -- | -$8.65M | $1.50M | -$25.37M | -- |
| Interest Income | $2.37M | $842K | $815K | $877K | $952K | $1.04M | $1.20M | $1.46M |
| Interest Expense | $11K | $18K | $17K | $18K | $23K | $28K | $28K | $30K |
| Income Tax Expense | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| Net Income | $59.12M | -$5.14M | $169.7M | -$3.76M | -$7.74M | $2.52M | -$24.53M | -$12.53M |
| Basic EPS | $0.30 | -$0.03 | $0.88 | -- | -$0.04 | $0.01 | -$0.13 | -- |
| Diluted EPS | $0.30 | -$0.03 | $0.87 | -- | -$0.04 | $0.01 | -$0.13 | -- |
| Basic Shares Outstanding | 198.7M | 197.5M | 193.8M | -- | 191.8M | 191.6M | 190.7M | -- |
| Diluted Shares Outstanding | 199.6M | 197.5M | 195.2M | -- | 191.8M | 192.4M | 190.7M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $18.01M | $36.33M | $26.29M | $30.78M | $109.3M | $52.25M | $31.80M | $36.94M | $54.29M | $23.41M |
| Short-Term Investments | $73.46M | $86.29M | $99.72M | $116.1M | $46.03M | $71.02M | $59.03M | $87.67M | $72.06M | $107.1M |
| Cash & Short-Term Investments | $91.50M | $122.6M | $132.3M | $184.3M | $191.0M | $123.3M | $90.83M | $124.6M | $126.4M | $130.6M |
| Accounts Receivable, Net | $1.45M | $2.41M | $1.78M | $1.35M | $899K | $1.31M | $1.20M | $1.43M | $402K | $273K |
| Total Current Assets | $94.46M | $127.3M | $132.0M | $151.1M | $160.7M | $127.7M | $93.83M | $129.2M | $129.4M | $132.6M |
| Property, Plant & Equipment, Net | $32K | $3.31M | $4.67M | $5.07M | $5.98M | $6.93M | $8.68M | $10.14M | $12.18M | $6.95M |
| Goodwill | -- | -- | -- | -- | -- | -- | $0 | $22.47M | $24.36M | $24.36M |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $0 | $43.84M | $58.65M | $99.44M |
| Long-Term Investments | $0 | $0 | $6.28M | $37.36M | $35.69M | $0 | $0 | -- | $0 | $0 |
| Other Non-Current Assets | $130K | $34K | $0 | $103K | $61K | $44K | $293K | $0 | -- | -- |
| Total Non-Current Assets | $162K | $4.39M | $12.37M | $44.28M | $43.82M | $9.38M | $11.71M | $98.68M | $107.8M | $143.4M |
| Total Assets | $94.62M | $131.7M | $144.4M | $195.4M | $204.5M | $137.1M | $105.5M | $227.9M | $237.2M | $275.9M |
| Accounts Payable | $1.17M | $2.32M | $3.22M | $3.52M | $3.17M | $2.99M | $2.40M | $3.19M | $1.99M | $3.21M |
| Deferred Revenue (Current) | $0 | $7.57M | $11.79M | $16.46M | $0 | -- | -- | $0 | $2.74M | $15K |
| Total Current Liabilities | $6.01M | $15.62M | $22.49M | $32.86M | $11.22M | $9.54M | $7.83M | $11.24M | $14.63M | $10.59M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $0 | $2.86M | $0 | $6.00M | $0 | -- | -- | -- | $0 | $0 |
| Total Non-Current Liabilities | $12.04M | $18.72M | $15.90M | $25.71M | $23.82M | $25.57M | $24.96M | $16.43M | $40.06M | $62.33M |
| Total Liabilities | $18.04M | $34.34M | $38.38M | $58.57M | $35.05M | $35.11M | $32.79M | $27.67M | $54.69M | $72.91M |
| Total Debt (incl. Leases) | $746K | $1.29M | $1.77M | $2.19M | $2.61M | $2.98M | $3.36M | -- | -- | -- |
| Common Stock | $1.42B | $1.41B | $1.35B | $1.32B | $1.29B | $985.9M | $898.5M | $879.4M | $876.1M | $867.4M |
| Retained Earnings | -$1.38B | -$1.35B | -$1.28B | -$1.20B | -$1.13B | -$1.05B | -$970.1M | -$805.2M | -$738.1M | -$652.7M |
| Accumulated Other Comp. Income | -$48.10M | -$48.13M | -$48.42M | -$50.49M | -$48.34M | -$48.17M | -$48.23M | -$48.17M | -$48.19M | -$48.19M |
| Total Stockholders' Equity | $76.58M | $97.37M | $106.0M | $136.9M | $169.4M | $102.0M | $72.74M | $200.2M | $182.5M | $203.0M |
| Total Equity | $76.58M | $97.37M | $106.0M | $136.9M | $169.4M | $102.0M | $72.74M | $200.2M | $182.5M | $203.0M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $264.2M | $19.17M | $23.71M | $18.01M | $22.41M | $37.41M | $37.08M | $36.33M |
| Short-Term Investments | $73.30M | $73.45M | $71.52M | $73.46M | $71.29M | $60.68M | $75.63M | $86.29M |
| Cash & Short-Term Investments | $337.5M | $92.62M | $95.23M | $91.50M | $93.70M | $98.09M | $112.7M | $122.6M |
| Accounts Receivable, Net | $792K | $369K | $1.31M | $1.45M | $905K | $1.02M | $1.18M | $2.41M |
| Total Current Assets | $339.6M | $273.9M | $277.0M | $94.46M | $97.44M | $103.1M | $116.8M | $127.3M |
| Property, Plant & Equipment, Net | $0 | $10K | $22K | $32K | $137K | $148K | $168K | $3.31M |
| Long-Term Investments | -- | -- | -- | $0 | -- | -- | -- | $0 |
| Other Non-Current Assets | $131K | $132K | $131K | $130K | $131K | $0 | $34K | $34K |
| Total Non-Current Assets | $131K | $142K | $153K | $162K | $268K | $148K | $202K | $4.39M |
| Total Assets | $339.7M | $274.0M | $277.2M | $94.62M | $97.71M | $103.3M | $117.0M | $131.7M |
| Accounts Payable | $320K | $373K | $1.46M | $1.17M | $1.01M | $1.32M | $2.24M | $2.32M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $0 | $0 | $6.76M | $7.57M |
| Total Current Liabilities | $241.9M | $3.36M | $5.11M | $6.01M | $5.18M | $5.02M | $19.43M | $15.62M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $0 | $0 | $2.86M | $2.86M |
| Total Non-Current Liabilities | $12.02M | $11.93M | $11.88M | $12.04M | $15.13M | $15.27M | $18.42M | $18.72M |
| Total Liabilities | $254.0M | $15.29M | $16.99M | $18.04M | $20.31M | $20.29M | $37.85M | $34.34M |
| Total Debt (incl. Leases) | $328K | $514K | $631K | $746K | $922K | $1.09M | $1.19M | $1.29M |
| Common Stock | $1.46B | $1.45B | $1.44B | $1.42B | $1.42B | $1.42B | $1.42B | $1.41B |
| Retained Earnings | -$1.16B | -$1.22B | -$1.21B | -$1.38B | -$1.38B | -$1.37B | -$1.37B | -$1.35B |
| Accumulated Other Comp. Income | -$48.29M | -$48.24M | -$48.20M | -$48.10M | -$48.13M | -$48.19M | -$48.17M | -$48.13M |
| Total Stockholders' Equity | $85.75M | $258.7M | $260.2M | $76.58M | $77.40M | $82.98M | $79.16M | $97.37M |
| Total Equity | $85.75M | $258.7M | $260.2M | $76.58M | $77.40M | $82.98M | $79.16M | $97.37M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$33.50M | -$69.92M | -$72.85M | -$69.46M | -$76.25M | -$63.74M | -$153.7M | -$57.06M | -$84.41M | -$384.2M |
| Depreciation & Amortization | $363K | $1.38M | $1.40M | $1.43M | $1.75M | $1.98M | $2.03M | $2.18M | $2.03M | $1.09M |
| Stock-Based Compensation | $6.95M | $8.99M | $9.30M | $7.18M | $6.42M | $6.16M | $6.80M | $6.24M | $15.12M | $39.16M |
| Change in Receivables | $1.38M | -$633K | -$424K | -$453K | $413K | -$108K | $227K | -$1.03M | -$129K | $735K |
| Operating Cash Flow | -$39.64M | -$64.85M | -$85.94M | -$35.36M | -$67.53M | -$51.44M | -$71.01M | -$67.87M | -$48.64M | -$57.88M |
| Capital Expenditure | $0 | -$182K | -$1.01M | -$512K | -$809K | -$229K | -$589K | -$1.14M | -$7.26M | -$4.00M |
| Free Cash Flow | -$39.64M | -$65.03M | -$86.94M | -$35.87M | -$68.34M | -$51.67M | -$71.59M | -$69.00M | -$55.90M | -$61.88M |
| Purchases of Investments | -$140.1M | -$141.5M | -$80.51M | -$130.4M | -$82.22M | -$85.58M | -$58.76M | -$121.6M | -- | -- |
| Sales & Maturities of Investments | $155.3M | $164.6M | $132.3M | $56.00M | $70.35M | $73.40M | $87.67M | $118.6M | -- | -- |
| Investing Cash Flow | $15.58M | $22.95M | $50.77M | -$74.94M | -$12.68M | -$14.91M | $28.34M | -$4.13M | $27.82M | -$99.12M |
| Common Stock Issued | -- | -- | -- | -- | $134.7M | $86.30M | $18.60M | $0 | $0 | $0 |
| Financing Cash Flow | $5.72M | $52.00M | $30.65M | $31.81M | $137.2M | $86.75M | $37.46M | $55.65M | $49.32M | $12.64M |
| Net Change in Cash | -$18.32M | $10.04M | -$4.49M | -$78.51M | $57.03M | $20.45M | -$5.14M | -$17.35M | $30.88M | -$143.4M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $59.12M | -$5.14M | $169.7M | -$3.76M | -$7.74M | $2.52M | -$24.53M | -$12.53M |
| Depreciation & Amortization | $10K | $11K | $11K | -- | $11K | $11K | $330K | -- |
| Stock-Based Compensation | $1.19M | $1.62M | $1.36M | $1.26M | $1.26M | $864K | $3.56M | $1.63M |
| Change in Receivables | -$423K | -$82K | $1.16M | -$129K | $120K | $157K | $1.23M | -$801K |
| Operating Cash Flow | $239.8M | -$6.02M | -$8.11M | -$4.68M | -$5.82M | -$15.75M | -$13.39M | -$10.31M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | -$86K |
| Free Cash Flow | -- | -- | -- | -$4.68M | -$5.82M | -$15.75M | -$13.39M | -$10.40M |
| Purchases of Investments | -$29.50M | -$23.66M | -$13.80M | -$25.55M | -$51.30M | -$28.50M | -$34.72M | -$43.19M |
| Sales & Maturities of Investments | $30.00M | $22.00M | $16.00M | $23.83M | $41.28M | $44.10M | $46.06M | $56.69M |
| Investing Cash Flow | $504K | -$1.66M | $2.20M | -$1.36M | -$10.02M | $15.61M | $11.35M | $13.41M |
| Financing Cash Flow | $4.71M | $3.15M | $11.62M | $1.64M | $844K | $453K | $2.78M | $1.42M |
| Net Change in Cash | $245.0M | -$4.54M | $5.70M | -$4.40M | -$15.00M | $336K | $746K | $4.48M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -271.0% | -1236.7% | -430.5% | -167.8% | -669.1% | -836.1% | -2394.0% | -1510.2% | -1036.7% | -32973.8% |
| Net Profit Margin | -237.9% | -1133.0% | -401.6% | -178.0% | -693.9% | -922.0% | -2557.4% | -959.8% | -788.9% | -25765.5% |
| Return on Equity (ROE) | -43.7% | -71.8% | -68.7% | -50.8% | -45.0% | -62.5% | -211.3% | -28.5% | -46.3% | -189.2% |
| Return on Assets (ROA) | -35.4% | -53.1% | -50.4% | -35.5% | -37.3% | -46.5% | -145.7% | -25.0% | -35.6% | -139.2% |
| Current Ratio | 15.73x | 8.15x | 5.87x | 4.60x | 14.32x | 13.38x | 11.99x | 11.50x | 8.84x | 12.52x |
| Quick Ratio | 15.48x | 8.00x | 5.96x | 5.65x | 17.10x | 13.06x | 11.76x | 11.22x | 8.67x | 12.36x |
| Debt to Equity | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.03x | 0.05x | -- | -- | -- |
| Revenue Growth (YoY) | +128.2% | -66.0% | -53.5% | +255.1% | +58.9% | +15.0% | +1.1% | -44.4% | +617.6% | -93.6% |
| 5Y Revenue / Share Growth | -19.4% | -68.4% | +1.7% | +32.2% | +268.2% | -82.2% | -84.8% | -89.4% | -81.0% | -98.1% |
| 10Y Revenue / Share Growth | -85.6% | -95.2% | -89.2% | -74.8% | -93.0% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -- | -171.5% | -- |
| 10Y Net Income / Share Growth | -- | -- | -- | -121.3% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 81.1% | 82.0% | 81.7% | -271.0% | -320.4% | -386.5% | -1290.9% | -1236.7% |
| Net Profit Margin | 121.2% | 84.2% | 84.0% | -237.9% | -289.4% | -351.9% | -1195.9% | -1133.0% |
| Return on Equity (ROE) | 256.5% | 59.2% | 61.8% | -43.7% | -54.6% | -65.4% | -96.7% | -71.8% |
| Return on Assets (ROA) | 64.7% | 55.9% | 58.0% | -35.4% | -43.3% | -52.5% | -65.4% | -53.1% |
| Current Ratio | 1.40x | 81.42x | 54.26x | 15.73x | 18.80x | 20.53x | 6.01x | 8.15x |
| Quick Ratio | 1.40x | 27.64x | 18.91x | 15.48x | 18.25x | 19.74x | 5.86x | 8.00x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.02x | 0.01x |
| Revenue Growth (YoY) | -43.5% | -90.6% | +10054.5% | -33.2% | -60.5% | +522.2% | +15.1% | -26.6% |
| Operating Income Growth (YoY) | -- | -500.8% | -- | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -303.8% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -400.0% | -- | -- | -- | -- | -- | -- |